A phase II clinical trial of HPP737 in Atopic Dermatitis
Latest Information Update: 24 Feb 2021
At a glance
- Drugs HPP 737 (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Newsoara Biopharma
- 24 Feb 2021 New trial record
- 17 Feb 2021 According to a vTv Therapeutics media release, the company expects to initiate this trial in 2021.